Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00999037
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:08.330205+00:00
Published At
2017-03-31T00:00:00+00:00
Record Updated At
2023-05-31
Results Posted At
2017-03-31
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Secondary Hyperparathyroidism"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-05-31"
protocolSection.identificationModule.nctId
"NCT00999037"
protocolSection.identificationModule.officialTitle
"FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney Disease"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-03-31"

Study condition terms

  • Secondary Hyperparathyroidism (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.